Lentiviral Mediated Gene Therapy for Pyruvate Kinase Deficiency: A Global Phase 1 Study for Adult and Pediatric Patients

MLA

José C. Segovia, et al. “Lentiviral Mediated Gene Therapy for Pyruvate Kinase Deficiency: A Global Phase 1 Study for Adult and Pediatric Patients.” Blood, vol. 136, Nov. 2020, p. 47. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........838aa0e2ffdb12d95e44047b65f08892&authtype=sso&custid=ns315887.

APA

José C. Segovia, Julián Sevilla, Susana Navarro, Gayatri R Rao, Miriam Zeini, Eileen Nicoletti, Jose Luis Lopez Lorenzo, Oscar Quintana Bustamante, Brian C. Beard, Sol Sanchez, Lucía Llanos, Begoña Pérez Camino de Gaisse, Juan A. Bueren, Grace Choi, Ami J. Shah, Maria Grazia Roncarolo, Jonathan D. Schwartz, May Chien, Bertil Glader, & Kenneth Law. (2020). Lentiviral Mediated Gene Therapy for Pyruvate Kinase Deficiency: A Global Phase 1 Study for Adult and Pediatric Patients. Blood, 136, 47.

Chicago

José C. Segovia, Julián Sevilla, Susana Navarro, Gayatri R Rao, Miriam Zeini, Eileen Nicoletti, Jose Luis Lopez Lorenzo, et al. 2020. “Lentiviral Mediated Gene Therapy for Pyruvate Kinase Deficiency: A Global Phase 1 Study for Adult and Pediatric Patients.” Blood 136 (November): 47. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........838aa0e2ffdb12d95e44047b65f08892&authtype=sso&custid=ns315887.